Oncology
Citations 3761-3770 of 19482 total displayed.
Past content
(since Oct 1840):
|
-
- Practice
- Bisphosphonates linked to osteonecrosis of the jaw
-
-
BMJ 2006;333:1213, doi: 10.1136/bmj.333.7580.1213-a, (Published 9 December 2006)
-
[Extract]
[Full text]
[PDF]
-
- Letters
- How much will Herceptin really cost?: Summary of other responses
- Birte Twisselmann
-
BMJ 2006;333:1219, doi: 10.1136/bmj.39052.659456.FA, (Published 9 December 2006)
-
[Extract]
[Full text]
[PDF]
-
- Letters
- How much will Herceptin really cost?: Balancing local and national priorities is not new
- Andrew Dillon and Peter Littlejohns
-
BMJ 2006;333:1219, doi: 10.1136/bmj.39051.733715.3A, (Published 9 December 2006)
-
[Extract]
[Full text]
[PDF]
-
- Editor's choice
- US Highlights
- Birte Twisselmann
-
BMJ 2006;333:, doi: 10.1136/bmj.39042.724907.3A, (Published 25 November 2006)
-
[Extract]
[Full text]
-
- Clinical review
- Clinically localised prostate cancer
- Timothy J Wilt and Ian M Thompson
-
BMJ 2006;333:1102, doi: 10.1136/bmj.39022.423588.DE, (Published 25 November 2006)
-
[Extract]
[Full text]
[PDF]
-
- Practice
- Obesity and cancer
- Donald C McMillan, Naveed Sattar, Mike Lean, and Colin S McArdle
-
BMJ 2006;333:1109, doi: 10.1136/bmj.39042.565035.BE1, (Published 25 November 2006)
-
[Extract]
[Full text]
[PDF]
-
- Practice
- Inappropriate prostate cancer screening is common among elderly US men
-
-
BMJ 2006;333:1112, doi: 10.1136/bmj.333.7578.1112-c, (Published 25 November 2006)
-
[Extract]
[Full text]
[PDF]
-
- Analysis and Comment
- How much will Herceptin really cost?
- Ann Barrett, Tom Roques, Matthew Small, and Richard D Smith
-
BMJ 2006;333:1118, doi: 10.1136/bmj.39008.624051.BE, (Published 25 November 2006)
-
[Full text]
[PDF]
-
- Letters
- Osteonecrosis of the jaw and bisphosphonates: Editorial was confusing
- Mark J Bolland, Andrew Grey, and Ian R Reid
-
BMJ 2006;333:1122, doi: 10.1136/bmj.39037.696759.3A, (Published 25 November 2006)
-
[Extract]
[Full text]
[PDF]
-
- Editorials
- Osteonecrosis of the jaw after treatment with bisphosphonates: Is irreversible, so the focus must be on prevention
- Basile Nicolas Landis, Michel Richter, Ivan Dojcinovic, and Max Hugentobler
-
BMJ 2006;333:982, doi: 10.1136/bmj.39024.647558.BE, (Published 11 November 2006)
-
[Extract]
[Full text]
[PDF]
|